Moderna Inc. (MRNA): Price and Financial Metrics

Moderna Inc. (MRNA): $137.90

2.13 (-1.52%)

POWR Rating

Component Grades








Add MRNA to Watchlist
Sign Up

Industry: Biotech




#244 of 351

in industry

MRNA Price/Volume Stats

Current price $137.90 52-week high $170.47
Prev. close $140.03 52-week low $62.55
Day low $135.27 Volume 3,380,478
Day high $139.92 Avg. volume 4,187,568
50-day MA $128.38 Dividend yield N/A
200-day MA $103.01 Market Cap 52.85B

MRNA Stock Price Chart Interactive Chart >

Moderna Inc. (MRNA) Company Bio

Moderna, Inc. (/məˈdɜːrnə/ mə-DUR-nə) is an American pharmaceutical and biotechnology company based in Cambridge, Massachusetts that focuses on RNA therapeutics, primarily mRNA vaccines. These vaccines use a copy of a molecule called messenger RNA (mRNA) to produce an immune response. (Source:Wikipedia)

MRNA Latest News Stream

Event/Time News Detail
Loading, please wait...

MRNA Latest Social Stream

Loading social stream, please wait...

View Full MRNA Social Stream

Latest MRNA News From Around the Web

Below are the latest news stories about MODERNA INC that investors may wish to consider to help them evaluate MRNA as an investment opportunity.

Tech Stalls As Rising Bond Yields Spook Investors

It's been an inauspicious start to the 2024 trading year, with all three major indexes in the red midday. | January 2, 2024

The Biggest Losers in S&P 500 This Year: Dollar General, Moderna, and More

The five worst performers in the market benchmark so far this year could be set for brighter futures.

Yahoo | December 28, 2023

Walgreens, Nike, Moderna: Bargain hunting stocks

The most recent bull market run has been widely described as "weird," with several household stocks underperforming during the bull run on S&P 500 (^GSPC) components. Yahoo Finance Reporter Madison Mills showcases three of these companies — Moderna (MRNA), Walgreens (WBA), and Nike (NKE) — where investors may find the most value for a bargain price on the stocks. For more expert insight and the latest market action, click here to watch this full episode of Yahoo Finance Live.

Yahoo | December 28, 2023

S&P 500 Is Nearing a Record High. This Could Derail It in 2024.

Microsoft and OpenAI are sued by the New York Times for copyright infringement, Amazon plans to launch adverts on Prime Video next month, and other news to start your day.

Yahoo | December 28, 2023

The Winners and Losers: 2023 Stock Market Performance Review

The 2023 stock market saw steep declines followed by rapid upswings, but we're ending the year on a high note (even if some stocks aren't).

Jeremy Flint on InvestorPlace | December 27, 2023

Read More 'MRNA' Stories Here

MRNA Price Returns

1-mo 3.76%
3-mo 31.20%
6-mo 60.00%
1-year 7.12%
3-year -30.77%
5-year 789.68%
YTD 38.66%
2023 -44.63%
2022 -29.28%
2021 143.11%
2020 434.10%
2019 28.09%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!